Journal
PHARMACEUTICALS
Volume 11, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/ph11040136
Keywords
neuroinflammation; microglia; carbon-11; radiochemistry; positron emission tomography
Categories
Funding
- US Department of Energy/National Institute of Biomedical Imaging and Bioengineering [DE-SC0012484]
- University of Michigan (College of Pharmacy)
- U.S. Department of Energy (DOE) [DE-SC0012484] Funding Source: U.S. Department of Energy (DOE)
Ask authors/readers for more resources
Positron emission tomography (PET) imaging of Colony Stimulating Factor 1 Receptor (CSF1R) is a new strategy for quantifying both neuroinflammation and inflammation in the periphery since CSF1R is expressed on microglia and macrophages. AZ683 has high affinity for CSF1R (K-i = 8 nM; IC50 = 6 nM) and >250-fold selectivity over 95 other kinases. In this paper, we report the radiosynthesis of [C-11]AZ683 and initial evaluation of its use in CSF1R PET. [C-11]AZ683 was synthesized by C-11-methylation of the desmethyl precursor with [C-11]MeOTf in 3.0% non-corrected activity yield (based upon [C-11]MeOTf, >99% radiochemical purity and high molar activity. Preliminary PET imaging with [C-11]AZ683 revealed low brain uptake in rodents and nonhuman primates, suggesting that imaging neuroinflammation could be challenging but that the radiopharmaceutical could still be useful for peripheral imaging of inflammation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available